中华交易服务香港生物科技指数上涨4.33%，前十大权重包含金斯瑞生物科技等

Core Viewpoint - The Hong Kong Biotechnology Index, managed by China Securities Trading Services, has shown significant growth, with a year-to-date increase of 117.31% [1][2] Group 1: Index Performance - The Hong Kong Biotechnology Index rose by 4.33% to 9737.36 points, with a trading volume of 22.125 billion [1] - Over the past month, the index has increased by 33.88%, and over the last three months, it has risen by 64.29% [1] Group 2: Index Composition - The index is composed entirely of companies listed on the Hong Kong Stock Exchange, with a 100% allocation in the healthcare sector [2] - The top ten holdings in the index include: - CanSino Biologics (13.26%) - Innovent Biologics (9.98%) - WuXi Biologics (9.61%) - 3SBio (9.24%) - BeiGene (8.51%) - WuXi AppTec (6.21%) - Zai Lab (5.1%) - Kelun-Biotech (4.61%) - Genscript Biotech (4.07%) - Legend Biotech-B (4.05%) [1]